Sched.com Conference Mobile Apps
BD&L Summit 2021 has ended
Create Your Own Event
BD&L Summit 2021
-
Saved To
My Schedule
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Attendees
Search
or browse by date + venue
Main Conference Day 1
All
Business Development
Main Conference Day 2
All
Due Diligence
Legal
Popular
menu
Menu
Schedule
Speakers
Attendees
Search
Brian Axe
NOVAQUEST CAPITAL MANAGEMENT
Principal
SE
Steven E. Cohen, M.D.
DAIICHI SANKYO, INC.
Executive Director, Search & Evaluation in Specialty Medicine, Global...
William Coppola
AERIE PHARMACEUTICALS
Intellectual Property Counsel
Rich Daly
BEYONDSPRING PHARMACEUTICALS; SEED THERAPEUTICS
Chief Operating Officer
Niels Emmerich
ABBVIE
Vice President, Global Head Search & Evaluation
Selina Estwick
ELI LILLY
Manager- Lilly Research Labs, Technical Transfer & Due Diligence
Michael Flaschen
MERCK
Head of HQ Transactions,
Jennifer Friel Goldstein
SILICON VALLEY BANK
Managing Partner, Life Sciences & Healthcare, SVB Capital
John Goodall, PhD.
ASTRAZENECA
Due Diligence Director, Business Development Operations
Luba Greenwood, J.D.
BINNEY STREET CAPITAL, VENTURE CAPITAL, DANA-FARBER CANCER INSTITUTE; HARVARD UNIVERSITY
Managing Partner; Lecturer
John Gustofson
ABBVIE VENTURES
Managing Director
Christopher Haskell
BAYER
Vice President and Head, Open Innovation Center - North America West
Timothy Herpin
JOHNSON & JOHNSON
Vice President Business Development, Infectious Diseases and Vaccines
Ariel Jasie
eGENESIS, INC.
Chief Business Officer, General Counsel, & Corporate Secretary
Olga Kay
ROCHE MOLECULAR SYSTEMS (Diagnostics)
Senior IP Counsel
Adam Kundzewicz, Ph.D.
BOEHRINGER INGELHEIM
Global Head of Strategic Market Access Initiatives
Forrester Liddle
JOUNCE THERAPEUTICS, INC.
Senior Director of Transactions, Head of Intellectual Property
Ahmed Mousa
PIERIS PHARMACEUTICALS
SVP Corporate Operations & General Counsel
Adam Muzikant, Ph.D.
FLEXION THERAPEUTICS
Chief Business Officer
Michael Myers
ELI LILLY
Sr. Director - Lilly Research Labs, Due Diligence
Jason Okazaki
ASSEMBLY BIOSCIENCES
Chief Legal and Business Officer
Martin Picard
MERCK KGaA, Darmstadt, Germany
Head of External R&D, Global Research & Development
Cody Powers
ZS ASSOCIATES
Principal
Laura Randa
TUTELA PHARMACEUTICALS and EMEDGENE
Strategic Advisor and Member of the Advisory Board
Alex Santini
NEKTAR THERAPEUTICS
Senior VP - Market Access Executive
Ioannis Sapountzis
BOEHRINGER INGELHEIM
Corporate SVP and Global Head BD&L
Michael Shih
SANOFI
Head of Global Transactions, Sanofi Partnering
Chris Slavinsky
PHARMACOSMOS THERAPEUTICS, INC.
General Counsel
Catherine Angell Sohn, Pharm.D.
Chairman, BIOECLIPSE THERAPEUTICS;
Board Director: JAZZ, AXCELLA HEALTH, RUBIUS
Daniel B. Tumas, DVM, PhD, DACVP
GILEAD SCIENCES, INC.
Executive Director, Head of Search and Evaluation, Corporate...
Jeffrey Wade
LEXICON PHARMACEUTICALS, INC.
Executive Vice President, Corporate and Administrative Affairs and CFO
Alex Zisson
H.I.G. CAPITAL
Managing Director